Clinical Radiology
Volume 65, Issue 6 , Pages 431-439 , June 2010

Imaging manifestations of progressive multifocal leukoencephalopathy

  • R. Shah
    • ,
  • A.K. Bag

      Affiliations

    • Corresponding Author InformationGuarantor and correspondent: A. K. Bag, Division of Neuroradiology, Department of Radiology, 619 19th St S, WP-150, Birmingham, AL-35249-6830, USA. Tel.: +1 205 934 3920; fax: +1 205 975 9262.
    • ,
  • P.R. Chapman
    • ,
  • J.K. Curé

Received 25 November 2009 ,Revised 23 February 2010 ,Accepted 2 March 2010.

References 

  1. Padgett BL, Walker DL, ZuRhein GM, et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet. 1971;1:1257–1260
  2. Rosenbloom MA, Uphoff DF. The association of progressive multifocal leukoencephalopathy and sarcoidosis. Chest. 1983;83:572–575
  3. McCormick WF, Schochet SS, Sarles HE, et al. Progressive multifocal leukoencephalopathy in renal transplant recipients. Arch Intern Med. 1976;136:829–834
  4. Richardson EP. Progressive multifocal leukoencephalopathy. N Engl J Med. 1961;265:815–823
  5. Miller JR, Barrett RE, Britton CB, et al. Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. N Engl J Med. 1982;307:1436–1438
  6. Calabrese LH, Molloy ES. Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis. 2008;67(Suppl. 3):iii64–iii65
  7. Focosi D, Maggi F, Ceccherini-Nelli L, et al. Progressive multifocal leukoencephalopathy in autoimmune disorders. Gut. 2009;58:605
  8. Berger JR. Natalizumab. Drugs Today (Barc). 2006;42:639–655
  9. Freim Wahl SG, Folvik MR, Torp SH. Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature. Clin Neuropathol. 2007;26:68–73
  10. Bonavita S, Conforti R, Russo A, et al. Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab. Neurol Sci. 2008;29:37–39
  11. Calabrese LH, Molloy ES. Therapy: rituximab and PML risk-informed decisions needed!. Nat Rev Rheumatol. 2009;5:528–529
  12. Piccinni C, Sacripanti C, Poluzzi E, et al. Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. Eur J Clin Pharmacol. 2010;66:199–206
  13. Koralnik IJ, Schellingerhout D, Frosch MP. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14–2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med. 2004;350:1882–1893
  14. d'Arminio Monforte A, Cinque P, Mocroft A, et al. Changing incidence of central nervous system diseases in the EuroSIDA cohort.. Ann Neurol. 2004;55:320–328
  15. Antinori A, Cingolani A, Lorenzini P, et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol. 2003;9(Suppl. 1):47–53
  16. Viallard JF, Lazaro E, Lafon ME, et al. Successful cidofovir therapy of progressive multifocal leukoencephalopathy preceding angioimmunoblastic T-cell lymphoma. Leuk Lymphoma. 2005;46:1659–1662
  17. Herrlinger U, Schwarzler F, Beck R, et al. Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological disease. J Neurol. 2003;250:612–614
  18. Vollmer-Haase J, Young P, Ringelstein EB. Efficacy of camptothecin in progressive multifocal leucoencephalopathy. Lancet. 1997;349:1366
  19. Wenning W, Haghikia A, Laubenberger J, et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med. 2009;361:1075–1080
  20. Gheuens S, Pierone G, Peeters P, et al. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry. 2010;81:247–254
  21. Berger JR, Pall L, Lanska D, et al. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol. 1998;4:59–68
  22. Weber T, Turner RW, Frye S, et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis. 1994;169:1138–1141
  23. Fong IW, Britton CB, Luinstra KE, et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol. 1995;33:484–486
  24. McGuire D, Barhite S, Hollander H, et al. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol. 1995;37:395–399
  25. Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology. 1997;48:687–694
  26. Bag AK, Curó JK, Chapman PR, Roberson GH, Shah R. JC virus infection of brain. [Published online ahead of print Mar 18, 2010]. AJNR Am J Neuroradiol. 2010;http://www.ajnr.org/pap.dtl. Accessed Mar 26, 2010.
  27. Marzocchetti A, Di Giambenedetto S, Cingolani A, et al. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol. 2005;43:4175–4177
  28. Glass AJ, Venter M. Improved detection of JC virus in AIDS patients with progressive multifocal leukoencephalopathy by T-antigen specific fluorescence resonance energy transfer hybridization probe real-time PCR: evidence of diverse JC virus genotypes associated with progressive multifocal leukoencephalopathy in Southern Africa. J Med Virol. 2009;81:1929–1937
  29. Weber T. Progressive multifocal leukoencephalopathy. Neurol Clin. 2008;26:833–854x–xi
  30. Carroll BA, Lane B, Norman D, et al. Diagnosis of progressive multifocal leukoencephalopathy by computed tomography. Radiology. 1977;122:137–141
  31. Krupp LB, Lipton RB, Swerdlow ML, et al. Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol. 1985;17:344–349
  32. Trotot PM, Vazeux R, Yamashita HK, et al. MRI pattern of progressive multifocal leukoencephalopathy (PML) in AIDS. Pathological correlations. J Neuroradiol. 1990;17:233–254
  33. Guilleux MH, Steiner RE, Young IR. MR imaging in progressive multifocal leukoencephalopathy. AJNR Am J Neuroradiol. 1986;7:1033–1035
  34. Post MJ, Yiannoutsos C, Simpson D, et al. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. AJNR Am J Neuroradiol. 1999;20:1896–1906
  35. Whiteman ML, Post MJ, Berger JR, et al. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 1993;187:233–240
  36. Kastrup O, Maschke M, Diener HC, et al. Progressive multifocal leukoencephalopathy limited to the brain stem. Neuroradiology. 2002;44:227–229
  37. Mathew RM, Murnane M. MRI in PML: bilateral medullary lesions. Neurology. 2004;63:2380
  38. Svensson PA, Larsson EM. Infratentorial progressive multifocal leucoencephalopathy (PML) in a patient with SLE (2008: 4b). Eur Radiol. 2008;18:1526–1528
  39. Semmler A, Urbach H, Klockgether T, et al. Progressive multifocal leukoencephalopathy with selective involvement of the pyramidal tracts. Neurology. 2007;68:871
  40. Sobha N, Sinha S, Taly AB, et al. Progressive multifocal leucoencephalopathy with discrete involvement of pyramidal tract. J Neurol Neurosurg Psychiatry. 2005;76:24
  41. Boster A, Hreha S, Berger JR, et al. Progressive multifocal leukoencephalopathy and relapsing–remitting multiple sclerosis: a comparative study. Arch Neurol. 2009;66:593–599
  42. Mark AS, Atlas SW. Progressive multifocal leukoencephalopathy in patients with AIDS: appearance on MR images. Radiology. 1989;173:517–520
  43. Sarrazin JL, Soulie D, Derosier C, et al. MRI aspects of progressive multifocal leukoencephalopathy, J Neuroradiol. 1995;22:172–179
  44. Thurnher MM, Post MJ, Rieger A, et al. Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol. 2001;22:977–984
  45. Kuker W, Mader I, Nagele T, et al. Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control. Eur J Neurol. 2006;13:819–826
  46. Smith AB, Smirniotopoulos JG, Rushing EJ. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic–pathologic correlation. RadioGraphics. 2008;28:2033–2058
  47. Post MJ, Tate LG, Quencer RM, et al. CT, MR, and pathology in HIV encephalitis and meningitis. AJR Am J Roentgenol. 1988;151:373–380
  48. Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med. 2006;354:924–933
  49. Takeda S, Yamazaki K, Miyakawa T, et al. Progressive multifocal leukoencephalopathy showing extensive spinal cord involvement in a patient with lymphocytopenia. Neuropathology. 2009;29:485–493
  50. Bernal-Cano F, Joseph JT, Koralnik IJ. Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient. J Neurovirol. 2007;13:474–476
  51. da Pozzo S, Manara R, Tonello S, et al. Conventional and diffusion-weighted MRI in progressive multifocal leukoencephalopathy: new elements for identification and follow-up. Radiol Med. 2006;111:971–977
  52. Bergui M, Bradac GB, Oguz KK, et al. Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology. 2004;46:22–25
  53. Usiskin SI, Bainbridge A, Miller RF, et al. Progressive multifocal leukoencephalopathy: serial high-b-value diffusion-weighted MR imaging and apparent diffusion coefficient measurements to assess response to highly active antiretroviral therapy. AJNR Am J Neuroradiol. 2007;28:285–286
  54. Mukherjee P, Berman JI, Chung SW, et al. Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings. AJNR Am J Neuroradiol. 2008;29:632–641
  55. Huisman TA, Boltshauser E, Martin E, et al. Diffusion tensor imaging in progressive multifocal leukoencephalopathy: early predictor for demyelination?. AJNR Am J Neuroradiol. 2005;26:2153–2156
  56. Chang L, Ernst T, Tornatore C, et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology. 1997;48:836–845
  57. Iranzo A, Moreno A, Pujol J, et al. Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS. J Neurol Neurosurg Psychiatry. 1999;66:520–523
  58. Yoon JH, Bang OY, Kim HS. Progressive multifocal leukoencephalopathy in AIDS: proton MR spectroscopy patterns of asynchronous lesions confirmed by serial diffusion-weighted imaging and apparent diffusion coefficient mapping. J Clin Neurol. 2007;3:200–203
  59. Simone IL, Federico F, Tortorella C, et al. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry. 1998;64:516–523
  60. Ernst T, Chang L, Witt M, et al. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging. Radiology. 1999;210:539–543
  61. Iranzo A, Marti-Fabregas J, Domingo P, et al. Absence of thallium-201 brain uptake in progressive multifocal leukoencephalopathy in AIDS patients. Acta Neurol Scand. 1999;100:102–105
  62. Lee VW, Antonacci V, Tilak S, et al. Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS. Radiology. 1999;211:507–512
  63. O'Doherty MJ, Barrington SF, Campbell M, et al. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med. 1997;38:1575–1583
  64. Garrels K, Kucharczyk W, Wortzman G, et al. Progressive multifocal leukoencephalopathy: clinical and MR response to treatment. AJNR Am J Neuroradiol. 1996;17:597–600
  65. Sakai M, Inoue Y, Aoki S, et al. Follow-up magnetic resonance imaging findings in patients with progressive multifocal leukoencephalopathy: evaluation of long-term survivors under highly active antiretroviral therapy. Jpn J Radiol. 2009;27:69–77
  66. Gray F, Bazille C, Adle-Biassette H, et al. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol. 2005;11(Suppl. 3):16–22
  67. Tan K, Roda R, Ostrow L, et al. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology. 2009;72:1458–1464
  68. Falco V, Olmo M, del Saz SV, et al. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study. J Acquir Immune Defic Syndr. 2008;49:26–31
  69. De Luca A, Ammassari A, Pezzotti P, et al. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS. 2008;22:1759–1767
  70. Marzocchetti A, Tompkins T, Clifford DB, et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009;73:1551–1558
  71. Berger JR, Levy RM, Flomenhoft D, et al. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol. 1998;44:341–349
  72. McCombe JA, Auer RN, Maingat FG, et al. Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: outcome and epidemiology. Neurology. 2009;72:835–841
  73. Mader I, Herrlinger U, Klose U, et al. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology. 2003;45:717–721
  74. Cosottini M, Tavarelli C, Del Bono L, et al. Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy. Eur Radiol. 2008;18:1024–1030

PII: S0009-9260(10)00095-4

doi: 10.1016/j.crad.2010.03.001

Clinical Radiology
Volume 65, Issue 6 , Pages 431-439 , June 2010

Article Tools

* Image Usage & Resolution